Melosky, Barbara http://orcid.org/0000-0003-2865-659X
Kambartel, Kato http://orcid.org/0000-0003-4609-6901
Häntschel, Maik http://orcid.org/0000-0002-0610-1959
Bennetts, Margherita http://orcid.org/0000-0001-5198-5274
Nickens, Dana J.
Brinkmann, Julia
Kayser, Antonin http://orcid.org/0000-0001-6799-6293
Moran, Michael http://orcid.org/0000-0001-6900-0015
Cappuzzo, Federico http://orcid.org/0000-0002-6295-6767
Funding for this research was provided by:
Pfizer
Article History
Accepted: 17 October 2021
First Online: 23 November 2021
Declarations
:
: This research was sponsored by Pfizer Inc.
: BM reports receiving honoraria from AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Merck, Novartis, and Pfizer. KK declares no conflicts of interest. MH reports receiving advisory fees/honoraria from BMS GmbH & Co. KG, Boehringer Ingelheim, Chugai Pharma Germany GmbH, Pfizer Pharma GmbH, and Roche Pharma AG, and grants for scientific research from AstraZeneca. MB is a Pfizer employee and may hold Pfizer stock. DJN is a Pfizer employee and may hold Pfizer stock. JB is a Pfizer employee and may hold Pfizer stock. AK is a Pfizer employee and may hold Pfizer stock. MM was a Pfizer employee at the time of preparation of the publication and may hold Pfizer stock. He is currently an employee of AbbVie and owns stock in AbbVie. FC reports being a consultant and participating in advisory boards for AstraZeneca, Bristol Myers Squibb, Eli Lilly, MSD, Pfizer, Roche, and Takeda.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: BM, KK, MH, and FC were involved in interpreting the data. MB, DJN, JB, and MM designed the research, conducted the research, and analyzed and interpreted the data. AK conducted the research, and analyzed and interpreted the data. All authors contributed to the development of this manuscript, and read and approved the final version.